\-\ Texto\\:\\ \ \(0\)\
\-\ large\\,\\ palpable\\,\\ tender\\ mass\\ in\\ r\\ neck\\,\\ posterior\\ to\\ the\\ mandible\\.\ \(0\)\
\-\ recommended\\ followup\\ includes\\ placement\\ of\\ ppd\\,\\ check\\ hiv\\ status\\,\\ and\\ fna\\ of\\ the\\ mass\\ if\\ any\\ clinical\\ suspicion\\ of\\ neoplastic\\ process\\.\\ \\ \ \(0\)\
\-\ standard\\ poly\\-pharmacy\\ treatment\\ for\\ m\\.\\ tuberculum\\ infection\\ is\\ usually\\ therapeutic\\.\ \(0\)\
\-\ large\\ heterogeneous\\ mass\\ posterior\\ to\\ r\\ mandible\\,\\ displacing\\ adjacent\\ structures\\.\ \(0\)\
\-\ multiple\\ necrotic\\ appearing\\ nodes\\ in\\ anterior\\ cervical\\ chains\ \(0\)\
\-\ scrofula\\ \\-\\ infectious\\ cervical\\ lymphadenitis\ \(0\)\
\-\ infection\\/abcess\ \(0\)\
\-\ \\ \\ tb\ \(1\)\
\-\ \\ \\ atypical\\ mycobacterium\\ \\(usually\\ not\\ painful\\)\ \(0\)\
\-\ \\ \\ staph\\/strep\\ \\(would\\ expect\\ these\\ with\\ sicker\\,\\ febrile\\ presentation\\)\ \(0\)\
\-\ \\ \\ if\\ immune\\ status\\ is\\ in\\ question\\,\\ the\\ infectious\\ differential\\ expands\\ to\\ include\\ many\\ others\\ especially\\ fungal\\.\ \(0\)\
\-\ lympho\\-proliferative\ \(0\)\
\-\ \\ \\ lymphoma\ \(3\)\
\-\ \\ \\ sarcoid\ \(0\)\
\-\ \\ \\ zebras\\ including\\ castleman\\'s\\ and\\ kimura\\'s\\ diseases\\.\ \(0\)\
\-\ malignancy\\ \\-\\-\\ location\\ is\\ good\\ for\\ primary\\ parotid\\ tumor\\ or\\ oro\\-pharyngeal\\ mets\\.\ \(0\)\
\-\ benign\\ neoplasm\\ \\(lipoma\\/neuroma\\/hemangioma\\)\ \(0\)\
\-\ congenital\\ \\(branchial\\ cleft\\ cysts\\)\ \(0\)\
\-\ trauma\\/vascular\\ \\(no\\ history\\)\\ pseudo\\-aneurysm\\ or\\ a\\-v\\ fistula\\.\ \(0\)\
\-\ 30\\ y\\/o\\ woman\\ with\\ 2\\ week\\ history\\ of\\ painful\\ neck\\ mass\\.\ \(1\)\
\-\ afebrile\\,\\ and\\ generally\\ well\\ appearing\\.\ \(0\)\
\-\ reports\\ h\\/o\\ mycobacterial\\ infection\\ in\\ past\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mandible\\:\\ 0\\.18929315507663613\ \(0\)\
\-\ infection\\:\\ 0\\.16221396531518276\ \(0\)\
\-\ painful\\:\\ 0\\.15833278777129473\ \(0\)\
\-\ infectious\\:\\ 0\\.14405102422822066\ \(0\)\
\-\ sicker\\:\\ 0\\.14315154240350886\ \(0\)\
\-\ zebras\\:\\ 0\\.14315154240350886\ \(0\)\
\-\ appearing\\:\\ 0\\.14305461636938252\ \(0\)\
\-\ tuberculum\\:\\ 0\\.1367889410741484\ \(0\)\
\-\ mass\\:\\ 0\\.13676703981821972\ \(0\)\
\-\ scrofula\\:\\ 0\\.12877301139770914\ \(0\)\
\-\ kimura\\:\\ 0\\.12877301139770914\ \(0\)\
\-\ cervical\\:\\ 0\\.12822229963872483\ \(0\)\
\-\ status\\:\\ 0\\.1249360289221445\ \(0\)\
\-\ chains\\:\\ 0\\.12349305349946275\ \(0\)\
\-\ lymphadenitis\\:\\ 0\\.11789607258279962\ \(0\)\
\-\ mycobacterium\\:\\ 0\\.11503506344432936\ \(0\)\
\-\ usually\\:\\ 0\\.11270410496617972\ \(0\)\
\-\ expands\\:\\ 0\\.11261611468455324\ \(0\)\
\-\ castleman\\:\\ 0\\.11261611468455324\ \(0\)\
\-\ neck\\:\\ 0\\.10951575017108393\ \(0\)\
\-\ mycobacterial\\:\\ 0\\.10782403356452178\ \(0\)\
\-\ parotid\\:\\ 0\\.10625351335519274\ \(0\)\
\-\ fna\\:\\ 0\\.10482597459693385\ \(0\)\
\-\ displacing\\:\\ 0\\.10415812462941983\ \(0\)\
\-\ expect\\:\\ 0\\.10415812462941983\ \(0\)\
\-\ if\\:\\ 0\\.10401911319579663\ \(0\)\
\-\ branchial\\:\\ 0\\.10351754157699987\ \(0\)\
\-\ ppd\\:\\ 0\\.10173917586964372\ \(0\)\
\-\ check\\:\\ 0\\.10118851917042253\ \(0\)\
\-\ immune\\:\\ 0\\.0996437871438708\ \(0\)\
\-\ others\\:\\ 0\\.09429393110916912\ \(0\)\
\-\ posterior\\:\\ 0\\.09257638565367265\ \(0\)\
\-\ question\\:\\ 0\\.09232985784165222\ \(0\)\
\-\ febrile\\:\\ 0\\.09202514718611766\ \(0\)\
\-\ mets\\:\\ 0\\.09202514718611766\ \(0\)\
\-\ therapeutic\\:\\ 0\\.09058449342025178\ \(0\)\
\-\ large\\:\\ 0\\.08970139429678071\ \(0\)\
\-\ in\\:\\ 0\\.0890721954348474\ \(0\)\
\-\ hiv\\:\\ 0\\.08852355499522743\ \(0\)\
\-\ necrotic\\:\\ 0\\.08713805807239991\ \(0\)\
\-\ suspicion\\:\\ 0\\.08507032064133839\ \(0\)\
\-\ sarcoid\\:\\ 0\\.08394897902615253\ \(0\)\
\-\ standard\\:\\ 0\\.0830720969671148\ \(0\)\
\-\ neoplastic\\:\\ 0\\.08273461932183268\ \(0\)\
\-\ diseases\\:\\ 0\\.08224163305021343\ \(0\)\
\-\ cleft\\:\\ 0\\.08084930208255622\ \(0\)\
\-\ fistula\\:\\ 0\\.08084930208255622\ \(0\)\
\-\ fungal\\:\\ 0\\.08012603555707783\ \(0\)\
\-\ tb\\:\\ 0\\.07970755460534226\ \(0\)\
\-\ followup\\:\\ 0\\.07903397026696658\ \(0\)\
\-\ afebrile\\:\\ 0\\.07728860584556613\ \(0\)\
\-\ nodes\\:\\ 0\\.07604164567024031\ \(0\)\
\-\ generally\\:\\ 0\\.07582519940154661\ \(0\)\
\-\ is\\:\\ 0\\.07354162434092634\ \(0\)\
\-\ atypical\\:\\ 0\\.07343698935030345\ \(0\)\
\-\ good\\:\\ 0\\.07280379255628688\ \(0\)\
\-\ recommended\\:\\ 0\\.07120374815068807\ \(0\)\
\-\ especially\\:\\ 0\\.07080846010375517\ \(0\)\
\-\ many\\:\\ 0\\.07057598021183319\ \(0\)\
\-\ of\\:\\ 0\\.07006956768520278\ \(0\)\
\-\ placement\\:\\ 0\\.0698985179281299\ \(0\)\
\-\ includes\\:\\ 0\\.06960656335433421\ \(0\)\
\-\ reports\\:\\ 0\\.06960656335433421\ \(0\)\
\-\ history\\:\\ 0\\.06839866307532726\ \(0\)\
\-\ cysts\\:\\ 0\\.0678307804970684\ \(0\)\
\-\ structures\\:\\ 0\\.06726009558110371\ \(0\)\
\-\ process\\:\\ 0\\.06713604666879291\ \(0\)\
\-\ to\\:\\ 0\\.06713458285390196\ \(0\)\
\-\ malignancy\\:\\ 0\\.06701297069914225\ \(0\)\
\-\ tender\\:\\ 0\\.06543953184278752\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.06478786287984761\ \(0\)\
\-\ congenital\\:\\ 0\\.0643162783048837\ \(0\)\
\-\ including\\:\\ 0\\.06406028395411628\ \(0\)\
\-\ would\\:\\ 0\\.06336495033202562\ \(0\)\
\-\ palpable\\:\\ 0\\.06288649541280783\ \(0\)\
\-\ location\\:\\ 0\\.06233096463195457\ \(0\)\
\-\ or\\:\\ 0\\.062280291884638204\ \(0\)\
\-\ presentation\\:\\ 0\\.06161958591062516\ \(0\)\
\-\ benign\\:\\ 0\\.06148971946716202\ \(0\)\
\-\ neoplasm\\:\\ 0\\.06110644681567707\ \(0\)\
\-\ 30\\:\\ 0\\.06106443312073142\ \(0\)\
\-\ week\\:\\ 0\\.06020717389718223\ \(0\)\
\-\ past\\:\\ 0\\.05826648678256058\ \(0\)\
\-\ differential\\:\\ 0\\.05816152247355033\ \(0\)\
\-\ adjacent\\:\\ 0\\.05802265337532293\ \(0\)\
\-\ any\\:\\ 0\\.05785077755311223\ \(0\)\
\-\ clinical\\:\\ 0\\.05672943593792636\ \(0\)\
\-\ and\\:\\ 0\\.05549059448513973\ \(0\)\
\-\ primary\\:\\ 0\\.05504113378190749\ \(0\)\
\-\ for\\:\\ 0\\.05426169788271365\ \(0\)\
\-\ the\\:\\ 0\\.05358354853184139\ \(0\)\
\-\ lymphoma\\:\\ 0\\.05331082029748318\ \(0\)\
\-\ include\\:\\ 0\\.053259705901512376\ \(0\)\
\-\ these\\:\\ 0\\.05054824825552749\ \(0\)\
\-\ anterior\\:\\ 0\\.04997909674511329\ \(0\)\
\-\ tumor\\:\\ 0\\.04682074380984627\ \(0\)\
\-\ woman\\:\\ 0\\.046618913301615536\ \(0\)\
\-\ multiple\\:\\ 0\\.043782991467750595\ \(0\)\
\-\ well\\:\\ 0\\.0433428685056511\ \(0\)\
\-\ treatment\\:\\ 0\\.04264002048223703\ \(0\)\
\-\ not\\:\\ 0\\.03533779278481546\ \(0\)\
\-\ with\\:\\ 0\\.035055717117599014\ \(0\)\
\-\ no\\:\\ 0\\.029108765297456967\ \(0\)\
